A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes

Name: A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes
License: Public Domain

Fujian Shengdi Pharmaceutical Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

type 2 diabetes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 407868
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.